Kaplan–Meier survival analysis for USP11 expression in prostate cancer patients showed that USP11 positivity was correlated with the biochemical recurrence-free survival of prostate cancer (p < 0.001) and clinical recurrence-free survival of prostate cancer (p < 0.001). This evidence concerns the gene USP11 and prostate carcinoma.